Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (271-280 of 377) with videos related to

Pageof 38
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.
Clinical Lung Cancer|April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative ResultsFilippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2015
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell CarcinomaFrancesco Massari, Chiara Ciccarese, Emilio Bria, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2025
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023)Giovanni Maria Iannantuono, Charalampos S Floudas, Marco Filetti, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
British Journal of Cancer|November 18, 2015
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancerFotios Loupakis, Roberto Moretto, Giuseppe Aprile, et al.
Plos One|December 14, 2012
True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugsMatteo Brunelli, Emilio Bria, Alessia Nottegar, et al.
Oncotarget|November 7, 2014
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancerEmilio Bria, Francesca Di Modugno, Isabella Sperduti, et al.
Scientific Reports|July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesMichele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.
Breast (Edinburgh, Scotland)|March 17, 2024
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Letizia Pontolillo, Carmine De Angelis, et al.
Pageof 38

Showing results (271-280 of 377) with videos related to

Sort By:
Pageof 38
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.
Clinical Lung Cancer|April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative ResultsFilippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2015
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell CarcinomaFrancesco Massari, Chiara Ciccarese, Emilio Bria, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2025
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023)Giovanni Maria Iannantuono, Charalampos S Floudas, Marco Filetti, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
British Journal of Cancer|November 18, 2015
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancerFotios Loupakis, Roberto Moretto, Giuseppe Aprile, et al.
Plos One|December 14, 2012
True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugsMatteo Brunelli, Emilio Bria, Alessia Nottegar, et al.
Oncotarget|November 7, 2014
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancerEmilio Bria, Francesca Di Modugno, Isabella Sperduti, et al.
Scientific Reports|July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesMichele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.
Breast (Edinburgh, Scotland)|March 17, 2024
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Letizia Pontolillo, Carmine De Angelis, et al.
Pageof 38